RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fulgent Genetics - Stock

Fulgent Genetics Revenue 2024

Fulgent Genetics Revenue

285.78 M USD

Fulgent Genetics Dividend yield

Ticker

FLGT

ISIN

US3596641098

WKN

A2AS4N

In 2024, Fulgent Genetics's sales reached 285.78 M USD, a -1.19% difference from the 289.21 M USD sales recorded in the previous year.

The Fulgent Genetics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e367.7428,40
2025e328.1831,83
2024e285.7836,55
2023289.2136,12
202261959,27
2021992.678,29
2020421.778,71
201932.556,62
201821.450,00
201718.754,55
201618.363,39
20159.646,88
20141.323,08

Fulgent Genetics Aktienanalyse

What does Fulgent Genetics do?

Fulgent Genetics Inc. is a US company founded in 2011 by Jianxing (Justin) Liu and Ming Hsieh. The company has undergone remarkable development and is now active in the field of genomics and genetics. Fulgent Genetics' business model is based on the development and distribution of solutions for the diagnosis of genetic diseases. The company offers a variety of products and services that enable doctors, clinics, and laboratories to make effective diagnoses based on genetics. One of Fulgent Genetics' main divisions is the Clinical Diagnostics department, which offers a wide range of diagnostic products that allow for both molecular diagnoses and the creation of clinical profiles for patients. This enables doctors and clinics to quickly and accurately detect and treat specific diseases. Another important division of Fulgent Genetics is the Research department, which focuses on the discovery and development of new technologies and testing procedures. These technologies and procedures are of great interest to the scientific community and are used in research or clinical studies. Fulgent Genetics also offers a Pharmacogenomics department, which is a growing segment in the personalized medicine market. The goal here is to tailor medications to the patient's genetic makeup. Fulgent Genetics' technology allows for the analysis of a patient's current genetic makeup and recommends medications based on that. Another important area of Fulgent Genetics is the direct-to-consumer sales of tests. This is particularly significant in the field of ancestry and genealogy research. Fulgent Genetics offers a variety of tests in this area and has already achieved great success. Overall, Fulgent Genetics offers a wide range of products and services mainly focused on the diagnosis of genetic diseases. However, the company also goes beyond that and provides solutions for a wide range of customers and applications. Fulgent Genetics is based in the US and has experienced rapid growth since its founding. The company's success is also reflected in the many awards it has received. It has been recognized multiple times and has established a reputation as one of the leading biotechnology companies in the world. Fulgent Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Fulgent Genetics's Sales Figures

The sales figures of Fulgent Genetics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Fulgent Genetics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Fulgent Genetics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Fulgent Genetics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Fulgent Genetics Stock

How much revenue did Fulgent Genetics generate this year?

Fulgent Genetics has achieved a revenue of 285.78 M USD this year.

How much was the turnover of the company Fulgent Genetics compared to the previous year?

The revenue of Fulgent Genetics has increased by -1.19% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Fulgent Genetics?

The revenue of Fulgent Genetics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Fulgent Genetics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Fulgent Genetics so important for investors?

The revenue of Fulgent Genetics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Fulgent Genetics pay?

Over the past 12 months, Fulgent Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fulgent Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fulgent Genetics?

The current dividend yield of Fulgent Genetics is .

When does Fulgent Genetics pay dividends?

Fulgent Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fulgent Genetics?

Fulgent Genetics paid dividends every year for the past 0 years.

What is the dividend of Fulgent Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fulgent Genetics located?

Fulgent Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fulgent Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fulgent Genetics from 6/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/8/2024.

When did Fulgent Genetics pay the last dividend?

The last dividend was paid out on 6/8/2024.

What was the dividend of Fulgent Genetics in the year 2023?

In the year 2023, Fulgent Genetics distributed 0 USD as dividends.

In which currency does Fulgent Genetics pay out the dividend?

The dividends of Fulgent Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Fulgent Genetics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Fulgent Genetics

Our stock analysis for Fulgent Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fulgent Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.